BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations, 2015.
Meetings conducted with Institutional Investors/Research Analysts.08-06-2023
08-06-2023
BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations, 2015.
Meetings conducted with Institutional Investors/Research Analysts.07-06-2023
Biocon share price gains as USFDA issues 'no observations' on Bengaluru facility
The share touched a 52-week high of Rs 344 and a 52-week low of Rs 191.60 on 10 June, 2022 and 21 March, 2023, respectively.05-06-2023
BIOCON LTD. - 532523 - Notification To Stock Exchange
'This is to inform you that the US FDA concluded a surveillance and pre-approval inspection of Biocon Pharma Limited Oral Solid Dosage formulations manufacturing facility at Bengaluru on 2nd June 2023, with no observations.' The above information will also be available on the website of the Company at www.biocon.com.03-06-2023
BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations, 2015.
Meetings conducted with Institutional Investors/Research Analysts.02-06-2023
BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations, 2015.
Meetings conducted with Institutional Investors/Research Analysts.02-06-2023
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
This is further to our earlier letter dated May 24, 2023 regarding presentation and video recording of Q4 and full year FY23 Earnings Call held on May 24, 2023, please find enclosed herewith the transcript of the Earnings Call. The same is also available on the website of the Company at https://www.biocon.com/investor-relations/financial-information/earning-call-transcripts/31-05-2023
BIOCON LTD. - 532523 - Intimation Under Regulation 30 (6) Of SEBI Listing Obligations And Disclosure Requirements (LODR) Regulations, 2015.
Meeting conducted with Institutional Investors/Research Analysts.31-05-2023
Hold Biocon; target of Rs 266: Sharekhan
Sharekhan recommended Hold rating on Biocon with a target price of Rs 266 in its research report date May 29, 2023.31-05-2023
BIOCON LTD. - 532523 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 ('SEBI Listing Regulation').
In Compliance with Regulation 23(9) of SEBI Listing Regulations, please find enclosed disclosure of related party transactions on consolidated basis for the half year ended on September 30, 2022 and March 31, 2023, drawn in accordance with applicable accounting standard. The above information will also be available on the website of the Company at www.biocon.com.26-05-2023